Mercado a Término de Buenos Aires has merged with ROFEX S.A.
Mercado a Término de Buenos Aires S.A. (MATba) has completed a US$275 million merge with ROFEX S.A., creating the largest futures exchange in Argentina.
MATba is the leading agricultural futures and options exchange in Latin America. Founded in 1907, it was the first market to be established in the continent, rapidly becoming a reference worldwide for some of its contracts.
Founded in 1909, ROFEX is the main financial futures and derivatives exchange in Argentina.
MATba and ROFEX started an integration process more than two years ago and with MATba shareholders’ approval during an extraordinary shareholders meeting held last December. Marcos Hermansonn, MATba’s Chairman and future MATba-ROFEX’s Vice-chairman, thanked the shareholders for their decision “as this demonstrates once again the significant importance that they give to a transcendent and vital decision to generate a large futures market in the Argentine Republic.”
Andres Ponte, ROFEX’s Chairman and future MATba-ROFEX’s Chairman, added: “This is great news in a difficult macroeconomic situation. We have managed to integrate two cultures in order to strengthen the Argentine capital market.”
Oaklins’ team in Argentina acted as the exclusive financial advisor in this transaction.


Talk to the deal team
Related deals
Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn moredoValue has finalized a rights issue
doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.
Learn more